141 related articles for article (PubMed ID: 38697112)
1. MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.
Liu Y; Flamier A; Bell GW; Diao AJ; Whitfield TW; Wang HC; Wu Y; Schulte F; Friesen M; Guo R; Mitalipova M; Liu XS; Vos SM; Young RA; Jaenisch R
Neuron; 2024 Jun; 112(12):1943-1958.e10. PubMed ID: 38697112
[TBL] [Abstract][Full Text] [Related]
2. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes.
Yasui DH; Peddada S; Bieda MC; Vallero RO; Hogart A; Nagarajan RP; Thatcher KN; Farnham PJ; Lasalle JM
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19416-21. PubMed ID: 18042715
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation in the gene body influences MeCP2-mediated gene repression.
Kinde B; Wu DY; Greenberg ME; Gabel HW
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the MET receptor tyrosine kinase gene by MeCP2 and sex-specific expression in autism and Rett syndrome.
Plummer JT; Evgrafov OV; Bergman MY; Friez M; Haiman CA; Levitt P; Aldinger KA
Transl Psychiatry; 2013 Oct; 3(10):e316. PubMed ID: 24150225
[TBL] [Abstract][Full Text] [Related]
5. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991
[TBL] [Abstract][Full Text] [Related]
7. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
8. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
9. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 Represses the Rate of Transcriptional Initiation of Highly Methylated Long Genes.
Boxer LD; Renthal W; Greben AW; Whitwam T; Silberfeld A; Stroud H; Li E; Yang MG; Kinde B; Griffith EC; Bonev B; Greenberg ME
Mol Cell; 2020 Jan; 77(2):294-309.e9. PubMed ID: 31784358
[TBL] [Abstract][Full Text] [Related]
11. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.
Forlani G; Giarda E; Ala U; Di Cunto F; Salani M; Tupler R; Kilstrup-Nielsen C; Landsberger N
Hum Mol Genet; 2010 Aug; 19(16):3114-23. PubMed ID: 20504995
[TBL] [Abstract][Full Text] [Related]
12. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.
Young JI; Hong EP; Castle JC; Crespo-Barreto J; Bowman AB; Rose MF; Kang D; Richman R; Johnson JM; Berget S; Zoghbi HY
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17551-8. PubMed ID: 16251272
[TBL] [Abstract][Full Text] [Related]
13. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
Nectoux J; Fichou Y; Rosas-Vargas H; Cagnard N; Bahi-Buisson N; Nusbaum P; Letourneur F; Chelly J; Bienvenu T
J Cell Mol Med; 2010 Jul; 14(7):1962-74. PubMed ID: 20569274
[TBL] [Abstract][Full Text] [Related]
14. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
Martínez de Paz A; Ausió J
Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
[TBL] [Abstract][Full Text] [Related]
16. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
[TBL] [Abstract][Full Text] [Related]
17. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
18. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
LaSalle JM; Goldstine J; Balmer D; Greco CM
Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
[TBL] [Abstract][Full Text] [Related]
19. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
[TBL] [Abstract][Full Text] [Related]
20. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
